Field narrowed to 6 in UCSB’s New Venture Competition
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Inogen earnings top Wall Street expectations again
Inogen, the Goleta-based maker of direct-to-consumer respiratory products, on April 27 reported fourth-quarter profit of $1.5 million. The company said it had net income of 7 cents per share. Earnings, adjusted for pretax gains, were 6 cents per share. Inogen, which produces oxygen concentrators for patients suffering from chronic respiratory conditions, posted revenue of $29.1 Read More →
Read More →UCSB to launch first professional school
With a curriculum that steers clear of heavy emphasis on typical MBA topics like accounting, the Master’s in Technology Management program will focus on the specific leadership and management skills needed by engineers and tech professionals.
Read More →Inogen raises 2014 guidance after beating on Q2 profits
Shares of Goleta-based Inogen climbed 4.3 percent in after-hours trading on Tuesday as the medical-device maker reported better-than-expected second-quarter revenue and profit. The company, which went public earlier this year, makes portable at-home oxygen concentrators. Its second-quarter revenue soared 50.8 percent to $30.4 million, beating the Capital IQ Consensus Estimate by $6.5 million. Product sales Read More →
Read More →Inogen gets FDA approval for at-home oxygen device
Goleta-based Inogen said it has received approval from the U.S. Food and Drug Administration to sell a stationary oxygen concentrator.
Read More →
Sponsored content:
2015-2016 Giving Guide
